Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
复制标题
N6-(1-亚氨基乙基)-L-赖氨酸在急性心脏移植排斥反应中的不同功效。
DOI:
10.1152/ajpheart.00356.2003
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Adams,MarkB
中科院分区:
文献类型:
--
作者:
Pieper,GalenM;Nilakantan,Vani;Hilton,Gail;Zhou,Xianghua;Khanna,AshwaniK;Halligan,NadineLN;Felix,ChristopherC;Kampalath,Bal;Griffith,OwenW;Hayward,MikeA;Roza,AllanM;Adams,MarkB
We examined the efficacy and mechanism of action ofN6-(1-iminoethyl)-l-lysine (l-NIL), a highly selective inhibitor of inducible nitric oxide (NO) synthase (iNOS), on acute cardiac transplant rejection.l-NIL produced a concentration-dependent attenuation of plasma NO by-products and a decrease in nitrosylation of heme protein without altering protein levels of iNOS. At postoperativeday 4,l-NIL did not alter the increased binding activities for transcription factors nuclear factor-κB and activator protein-1. Whereasl-NIL decreased inflammatory cell infiltration, graft survival was only prolonged at the dose of 1.0 μg/ml that incompletely blocked NO production. Higherl-NIL concentrations (30 and 60 μg/ml) ablated the increased NO production but failed to improve graft survival and even potentiated NF-κB binding activity examined atday 6. Alloimmune activation indicated by increased cytokine gene expression for interferon-γ, interleukin-6, and interleukin-10 was inhibited in grafts only by treatment with 1.0 μg/mll-NIL. These findings suggest a complex role of NO in acute cardiac allograft rejection. Partial inhibition of iNOS is beneficial to graft survival, whereas total ablation may oppose any benefits to graft survival. These studies have important implications in understanding the dual role of NO in acute rejection and help to reconcile discrepancies in the literature.